“Superparamagnetism enable our nanomaterials to create previously unimaginable possibilities,” says Dr. Jérémy Paris, CEO of SON. What is Superparamagnetism? Louis Néel discovered superparamagnetism in 1949 during a study on fired clay and lava (“Theory of Magnetic Drag of Fine-Grain Ferromagnetics with Applications to Fired Clays,” Louis Néel). The work of this Nobel Prize-winning physicist helped […]
SUPERPARAMAGNETISM
Nanomedicine research is experiencing significant growth, particularly in the use of nanoparticles for biomedical applications. Recently, a team of chemists from CNRS made a major breakthrough by exploring nanoparticles in the form of nanoflowers. They demonstrated the potential of iron oxide nanoparticles shaped as nanoflowers (SPIO – Superparamagnetic Iron Oxide Nanoparticles) for magnetic hyperthermia, an […]
Nanoflowers & nanomedicine
SON becomes the sponsor of the Master Innovative Drugs for the 2024-2025 academic year. SON is immensely proud to announce its role as the sponsor of the Master Innovative Drugs, a pioneering program in pharmaceutical sciences. At SON, education and knowledge transfer have always been at the core of our mission. This new collaboration aligns […]
SON becomes the sponsor of the Master Innovative Drugs
SON will be attending CPHI 2024 in Milan. Every year for the past 35 years, CPHI has brought together thought leaders, innovators, and pioneers in the pharmaceutical industry. Join SON to explore its functionalized nanomaterials, nanocatalysts, and gold nanoparticles at BOOTH 6 SU 100. Meet SON at CPHI 2024 We are excited to announce that […]
SON will be present at CPHI in Milan from October 8 to 10, 2024
A New Therapeutic Approach Some cancer patients can now benefit from a new therapeutic approach: theranostics. But what exactly is it? This technique combines both the diagnosis and treatment of tumors, offering an integrated and targeted approach. This method allows not only the identification of tumors via imaging but also their direct treatment. It represents […]
Theranostics: a revolution in cancer treatment
R-Nano declarations: time to ensure compliance With every new year come obligatory R-Nano declarations. But what are they? Nanoparticles possess innovative properties that could revolutionise the chemistry and healthcare of tomorrow. And yet, there are concerns about their use. It’s therefore crucial that the use of nanomaterials be closely monitored by public authorities to ensure […]
R-Nano Declarations
Today is the International Day of Women and Girls in Science. For SON, this has a very special meaning, as our team has an equal number of female and male scientists. That’s why, today, we want to pay homage not only to the women who make our company what it is but also to those […]
Women and Girls in Science
Stimulus package and nanocatalysts Two years ago, SON was granted a stimulus package for a joint project with the University of Burgundy. The project focused on the efficiency, reuse, and potential of our nanocatalysts. These nanocatalysts compensate for some of the problems encountered with conventional catalysis, such as high catalyst costs and the resulting pollution. […]
SON nanocatalysts
Coral reefs are critically endangered Global warming is a terrible threat to biodiversity. The effects on coral reefs and countless other organisms are already considerable. Coral reefs are veritable hotspots of marine biodiversity, and climate change is a direct and immediate threat to them. Rising ocean temperatures are already adversely affecting them. Oceanologists see the […]
What if nanoparticles could save the coral reefs?
We’re delighted to share some excellent news: SON has been awarded its CIR (Crédit d’impôt recherche – French research tax credit) accreditation for the next 3 years. What this means is that all our customers will be able to benefit from the research tax credit for their pursuits in research and development until 2026. The […]
SON and the CIR